# Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)

> **NCT06238596** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 38 (estimated)

## Conditions studied

- Metastatic Prostate Cancer (PCa) in ADT
- Rehabilitation

## Interventions

- **PROCEDURE:** rehabilitation

## Key facts

- **NCT ID:** NCT06238596
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-06
- **Primary completion:** 2025-03-03
- **Final completion:** 2026-05
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06238596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06238596, "Rehabilitation Intervention to Prevent Adverse Events Related to Androgen-deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer (PCa): a Single Arm Feasibility Study (ReCaP Study)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06238596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*